Table 2.
Age group | Breast cancer vs. no cancer | Breast cancer with tamoxifen vs. no cancer | Breast cancer without endocrine therapy vs. no cancer |
---|---|---|---|
OR (95% CI)* and p-values | OR (95% CI)* and p-values | OR (95% CI)* and p-values | |
Total | 2.39 (1.70–3.34) | 2.67 (1.58–4.53) | 1.63 (0.80–3.33) |
P <0.001 | P < 0.001 | p = 0.181 | |
Age 18–30 | 1.06 (0.07–16.86) | 0.00 | 2.08 (0.13–33.22) |
0.970 | p = 0.605 | ||
Age 31–40 | 3.98 (1.16–13.68) | 2.66 (1.18–5.98) | 2.12 (0.87–5.17) |
p = 0.028 | p = 0.018 | p = 0.098 | |
Age 41–50 | 2.25 (1.35–3.75) | 2.48 (1.64–3.76) | 2.02 (1.15–3.56) |
p = 0.002 | P < 0.001 | p = 0.015 |
multivariable Cox regression adjusted for BMI, smoking behavior, comorbidities, and corticosteroid therapy.